CompoAtlas

Probiotics 10

Natural health product licensed in Canada

Licence holder
Market America Inc.
NPN or DIN-HM
80118024
Status
Active licence
Licence date
20 April 2022
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Bifidobacterium breve

Source : CGMCC2124

200 Millions d'UFCNot calculated
Bifidobacterium breve

Source : Bifidobacterium breve - Cellule entière

200 Millions d'UFCNot calculated
Bifidobacterium longum subsp. longum

Source : SD-5844

200 Millions d'UFCNot calculated
Bifidobacterium longum subsp. longum

Source : Bifidobacterium longum subsp. longum - Cellule entière

200 Millions d'UFCNot calculated
Lactiplantibacillus plantarum

Source : SD-5870

5 Milliards d'UFCNot calculated
Lactiplantibacillus plantarum

Source : Lactiplantibacillus Plantarum - Cellule entière

5 Milliards d'UFCNot calculated
Lactobacillus acidophilus

Source : Lactobacillus acidophilus - Cellule entière

1.8 Milliards d'UFCNot calculated
Lactobacillus acidophilus

Source : NCIMB 30333

1.8 Milliards d'UFCNot calculated
Lacticaseibacillus rhamnosus

Source : SD-5839

1 Milliards d'UFCNot calculated
Ligilactobacillus Salivarius

Source : SD-5851

1 Milliards d'UFCNot calculated
Lacticaseibacillus casei

Source : SD-5842

200 Millions d'UFCNot calculated
Lacticaseibacillus paracasei

Source : DSM 13434

200 Millions d'UFCNot calculated
Bifidobacterium longum subsp. infantis

Source : SD-6669

200 Millions d'UFCNot calculated
Bifidobacterium longum subsp. infantis

Source : Bifidobacterium longum subsp. Infantis - Whole Cell

200 Millions d'UFCNot calculated
Bifidobacterium bifidum

Source : NCIMB 30353

200 Millions d'UFCNot calculated
Bifidobacterium bifidum

Source : Bifidobacterium bifidum - Cellule entière

200 Millions d'UFCNot calculated

Non-medicinal ingredients

Hydroxypropyl méthylcellulose, Gomme de Guar, Pectine, Curcuma, Cellulose microcristalline, Acide stéarique, Carbonate de sodium anhydre

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Comprimé1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80118024

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line